Impact of lactobacilli on orally acquired listeriosis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 41, 2012, Pages 16684-16689

  Archambaud, Cristel ^a,c,d   Nahori, Marie Anne ^a,c,d   Soubigou, Guillaume ^b   Bećavin, Christophe ^a,c,d   Laval, Laure ^e,f   Lechat, Pierre ^a   Smokvina, Tamara ^f   Langella, Philippe ^e   Lecuit, Marc ^a,c,g   Cossart, Pascale ^a,c,d  

^a INSTITUT PASTEUR   (France)

^b Parc Scientifique de Luminy   (France)

^c INSERM   (France)

^d CEMAGREF   (France)

^e UMR1319 MICALIS   (France)

^f DANONE RESEARCH   (France)

^g UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Probiotics; Virulence; Vitamin B12

Indexed keywords

CARBON; GAMMA INTERFERON; MICRORNA; NITROGEN; PROBIOTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; CARBON SOURCE; CYTOKINE PRODUCTION; GENE EXPRESSION; GENE REPRESSION; IMMUNE RESPONSE; INOCULATION; INTESTINE MUCOSA; LACTOBACILLUS CASEI; LACTOBACILLUS PARACASEI; LISTERIA MONOCYTOGENES; LISTERIOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN; TRANSCRIPTOMICS;

ANIMALS; ANTIBIOSIS; GENE EXPRESSION; GENES, BACTERIAL; HOST-PATHOGEN INTERACTIONS; INTERFERONS; INTESTINES; LACTOBACILLUS; LACTOBACILLUS CASEI; LISTERIA MONOCYTOGENES; LISTERIOSIS; MICE; MICE, TRANSGENIC; MICRORNAS; MOUTH; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTOME;

EID: 84867371461     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1212809109     Document Type: Article

References (54)

1. Sekirov I, Russell SL, Antunes LC, Finlay BB (2010) Gut microbiota in health and disease. Physiol Rev 90:859-904.
2. Gordon JI, Klaenhammer TR (2011) A rendezvous with our microbes. Proc Natl Acad Sci USA 108(Suppl 1):4513-4515.
3. Khor B, Gardet A, Xavier RJ (2011) Genetics and pathogenesis of inflammatory bowel disease. Nature 474:307-317.
4. Dominguez-Bello MG, Blaser MJ (2008) Do you have a probiotic in your future? Microbes Infect 10:1072- 1076.
5. Dobrogosz WJ, Peacock TJ, Hassan HM (2010) Evolution of the probiotic concept from conception to validation and acceptance in medical science. Adv Appl Microbiol 72:1-41.
6. Masood MI, Qadir MI, Shirazi JH, Khan IU (2011) Beneficial effects of lactic acid bacteria on human beings. Crit Rev Microbiol 37:91-98.
7. Cossart P (2011) Illuminating the landscape of host-pathogen interactions with the bacterium Listeria monocytogenes. Proc Natl Acad Sci USA 108:19484-19491.
8. Nikitas G, et al. (2011) Transcytosis of Listeriamonocytogenes across the intestinal barrier upon specific targeting of goblet cell accessible E-cadherin. J Exp Med 208:2263-2277.
9. Lecuit M, et al. (1999) A single amino acid in E-cadherin responsible for host specificity towards the human pathogen Listeria monocytogenes. EMBO J 18:3956-3963. (Pubitemid 29335848)
10. Disson O, et al. (2008) Conjugated action of two species-specific invasion proteins for fetoplacental listeriosis. Nature 455:1114-1118.
11. Lecuit M, et al. (2001) A transgenic model for listeriosis: Role of internalin in crossing the intestinal barrier. Science 292:1722-1725. (Pubitemid 32506246)
12. Coconnier MH, et al. (1993) Inhibition of adhesion of enteroinvasive pathogens to human intestinal Caco-2 cells by Lactobacillus acidophilus strain LB decreases bacterial invasion. FEMS Microbiol Lett 110:299-305.
13. Coconnier MH, Liévin V, Bernet-Camard MF, Hudault S, Servin AL (1997) Antibacterial effect of the adhering human Lactobacillus acidophilus strain LB. Antimicrob Agents Chemother 41:1046-1052. (Pubitemid 27194183)
14. Corr SC, Gahan CG, Hill C (2007) Impact of selected Lactobacillus and Bifidobacterium species on Listeria monocytogenes infection and the mucosal immune response. FEMS Immunol Med Microbiol 50:380-388. (Pubitemid 47041463)
15. de Waard R, Garssen J, Vos JG, Claassen E (2002) Modulation of delayed-type hypersensitivity and acquired cellular resistance by orally administered viable indigenous lactobacilli in Listeria monocytogenes infected Wistar rats. Lett Appl Microbiol 35:256- 260.
16. dos Santos LM, et al. (2011) Monoassociation with probiotic Lactobacillus delbrueckii UFV-H2b20 stimulates the immune system and protects germfree mice against Listeria monocytogenes infection. Med Microbiol Immunol (Berl) 200:29-38.
17. Kim YG, et al. (2006) Probiotic Lactobacillus casei activates innate immunity via NFkappaB and p38 MAP kinase signaling pathways. Microbes Infect 8:994-1005.
18. Sato K (1984) Enhancement of host resistance against Listeria infection by Lactobacillus casei: role of macrophages. Infect Immun 44:445-451.
19. Bambirra FH, et al. (2007) Protective effect of Lactobacillus sakei 2a against experimental challenge with Listeria monocytogenes in gnotobiotic mice. Lett Appl Microbiol 45:663- 667.
20. Corr SC, et al. (2007) Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118. Proc Natl Acad Sci USA 104:7617-7621. (Pubitemid 47185955)
21. Patent Application Publication (2011) Novel strain of Lactobacillus paracasei subspecies paracasei having antimicrobial and immunomodulary properties. US 2011/0150852 A1.
22. Rochat T, et al. (2007) Anti-inflammatory effects of Lactobacillus casei BL23 producing or not a manganese-dependant catalase on DSS-induced colitis inmice. Microb Cell Fact 6:22.
23. Lecuit M, Sonnenburg JL, Cossart P, Gordon JI (2007) Functional genomic studies of the intestinal response to a foodborne enteropathogen in a humanized gnotobiotic mouse model. J Biol Chem 282:15065-15072. (Pubitemid 47093333)
24. Bartel DP (2009) MicroRNAs: Target recognition and regulatory functions. Cell 136: 215-233.
25. Dalmasso G, et al. (2011) Microbiota modulate host gene expression via microRNAs. PLoS ONE 6:e19293.
26. Xue X, et al. (2011) Microbiota downregulates dendritic cell expression of miR-10a, which targets IL-12/IL-23p40. J Immunol 187:5879-5886.
27. Stavru F, Archambaud C, Cossart P (2011) Cell biology and immunology of Listeria monocytogenes infections: Novel insights. Immunol Rev 240:160-184.
28. Rutz S, Ouyang W (2011) Regulation of interleukin-10 and interleukin-22 expression in T helper cells. Curr Opin Immunol 23:605-612.
29. Liao W, Lin JX, Leonard WJ (2011) IL-2 family cytokines: New insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation. Curr Opin Immunol 23:598-604.
30. Mandin P, Repoila F, Vergassola M, Geissmann T, Cossart P (2007) Identification of new noncoding RNAs in Listeria monocytogenes and prediction of mRNA targets. Nucleic Acids Res 35:962-974. (Pubitemid 46344721)
31. Toledo-Arana A, et al. (2009) The Listeria transcriptional landscape from saprophytism to virulence. Nature 459:950-956.
32. Toledo-Arana A, Repoila F, Cossart P (2007) Small noncoding RNAs controlling pathogenesis. Curr Opin Microbiol 10:182-188. (Pubitemid 46590044)
33. Wurtzel O, et al. (2012) Comparative transcriptomics of pathogenic and non-pathogenic Listeria species. Mol Syst Biol 8:583.
34. MacMicking JD (2004) IFN-inducible GTPases and immunity to intracellular pathogens. Trends Immunol 25:601-609.
35. Kim BH, et al. (2011) A family of IFN-γ-inducible 65-kD GTPases protects against bacterial infection. Science 332:717-721.
36. Stockinger S, Decker T (2008) Novel functions of type I interferons revealed by infection studies with Listeria monocytogenes. Immunobiology 213:889-897.
37. Bierne H, et al. (2012) Activation of type III interferon genes by pathogenic bacteria in infected epithelial cells and mouse placenta. PLoS ONE 7:e39080.
38. Lebreton A, et al. (2011) A bacterial protein targets the BAHD1 chromatin complex to stimulate type III interferon response. Science 331:1319-1321.
39. Omiecinski CJ, Vanden Heuvel JP, Perdew GH, Peters JM (2011) Xenobiotic metabolism, disposition, and regulation by receptors: From biochemical phenomenon to predictors of major toxicities. Toxicol Sci 120(Suppl 1):S49-S75.
40. Kishimoto M, et al. (2006) Nuclear receptor mediated gene regulation through chromatin remodeling and histone modifications. Endocr J 53:157-172.
41. Zordoky BN, El-Kadi AO (2009) Role of NF-kappaB in the regulation of cytochrome P450 enzymes. Curr Drug Metab 10:164-178.
42. van Schaik RH (2008) CYP450 pharmacogenetics for personalizing cancer therapy. Drug Resist Updat 11:77-98.
43. Izar B, Mannala GK, Mraheil MA, Chakraborty T, Hain T (2012) microRNA response to Listeria monocytogenes infection in epithelial cells. Int J Mol Sci 13:1173-1185.
44. Schnitger AK, et al. (2011) Listeria monocytogenes infection in macrophages induces vacuolar-dependent host miRNA response. PLoS ONE 6:e27435.
45. Ma F, et al. (2011) The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-γ. Nat Immunol 12:861-869.
46. Kurashige J, et al. (2012) MicroRNA-200b regulates cell proliferation, invasion, and migration by directly targeting ZEB2 in gastric carcinoma. Ann Surg Oncol 19(Suppl 3):656-664.
47. Bobik TA, Havemann GD, Busch RJ, Williams DS, Aldrich HC (1999) The propanediol utilization (pdu) operon of Salmonella enterica serovar Typhimurium LT2 includes genes necessary for formation of polyhedral organelles involved in coenzyme B(12)-dependent 1, 2-propanediol degradation. J Bacteriol 181:5967-5975. (Pubitemid 29459906)
48. Tsoy O, Ravcheev D, Mushegian A (2009) Comparative genomics of ethanolamine utilization. J Bacteriol 191:7157-7164.
49. Buchrieser C, Rusniok C, Kunst F, Cossart P, Glaser P; Listeria Consortium (2003) Comparison of the genome sequences of Listeria monocytogenes and Listeria innocua: Clues for evolution and pathogenicity. FEMS Immunol Med Microbiol 35:207-213. (Pubitemid 36324451)
50. Garsin DA (2010) Ethanolamine utilization in bacterial pathogens: Roles and regulation. Nat Rev Microbiol 8:290-295.
51. Thiennimitr P, et al. (2011) Intestinal inflammation allows Salmonella to use ethanolamine to compete with the microbiota. Proc Natl Acad Sci USA 108:17480-17485.
52. Joseph B, et al. (2006) Identification of Listeria monocytogenes genes contributing to intracellular replication by expression profiling and mutant screening. J Bacteriol 188: 556-568. (Pubitemid 43100544)
53. Kamada N, et al. (2012) Regulated virulence controls the ability of a pathogen to compete with the gut microbiota. Science 336:1325-1329.
54. Bolstad BM, Irizarry RA, Astrand M, Speed TP (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19:185-193. (Pubitemid 36181903)